Literature DB >> 12584869

Need for medical and psychosocial services among injection drug users: a comparative study of needle exchange and methadone maintenance.

Michael D Stein1, Peter Friedmann.   

Abstract

This study compares the prevalence of perceived and unmet needs of HIV-negative injection drug users (IDUs) not receiving drug treatment (n = 251) and those recruited from a methadone maintenance program (n = 312) in 1998. We studied self-reported needs for six community services: medical, mental health, housing, income assistance, alcohol treatment, and drug treatment. Respondents reported the highest levels of need for mental health and housing services. Ninety-four percent of out-of-treatment IDUs reported having at least one need compared to 62% of methadone clients (p < .001). Across all reported service needs, at least 69% of respondents in both cohorts reported their needs were unmet. While HIV-infected drug users receive assistance through the Ryan White CARE Act, these findings suggest that seronegative drug users may benefit from similar community service programs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12584869     DOI: 10.1080/10550490290088063

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  9 in total

1.  Profiting and providing less care: comprehensive services at for-profit, nonprofit, and public opioid treatment programs in the United States.

Authors:  Marcus A Bachhuber; William N Southern; Chinazo O Cunningham
Journal:  Med Care       Date:  2014-05       Impact factor: 2.983

2.  Perceived stress and substance use in methadone-maintained smokers.

Authors:  Ethan Moitra; Bradley J Anderson; Michael D Stein
Journal:  Drug Alcohol Depend       Date:  2013-08-26       Impact factor: 4.492

3.  Adherence to hepatitis B virus vaccination at syringe exchange sites.

Authors:  Frederick L Altice; Robert D Bruce; Mary R Walton; Marta I Buitrago
Journal:  J Urban Health       Date:  2005-03-03       Impact factor: 3.671

4.  Inability to access health and social services associated with mental health among people who inject drugs in a Canadian setting.

Authors:  Linwei Wang; Dimitra Panagiotoglou; Jeong Eun Min; Kora DeBeck; M J Milloy; Thomas Kerr; Kanna Hayashi; Bohdan Nosyk
Journal:  Drug Alcohol Depend       Date:  2016-09-01       Impact factor: 4.492

5.  Healthcare utilization of individuals with opiate use disorders: an analysis of integrated medicaid and state mental health/substance abuse agency data.

Authors:  Jeremy Bray; Rita Vandivort; Joan Dilonardo; Laura Dunlap; Don Schroeder; Carol Forhan; Kay Miller
Journal:  J Behav Health Serv Res       Date:  2007-06-07       Impact factor: 1.505

6.  A syringe prescription program to prevent infectious disease and improve health of injection drug users.

Authors:  Josiah D Rich; Michelle McKenzie; Grace E Macalino; Lynn E Taylor; Stephanie Sanford-Colby; Francis Wolf; Susan McNamara; Meenakshi Mehrotra; Michael D Stein
Journal:  J Urban Health       Date:  2004-03       Impact factor: 3.671

7.  High prevalence of unmet healthcare need among people who use illicit drugs in a Canadian setting with publicly-funded interdisciplinary primary care clinics.

Authors:  Soroush Moallef; Fahmida Homayra; M-J Milloy; Lorna Bird; Bohdan Nosyk; Kanna Hayashi
Journal:  Subst Abus       Date:  2020-12-03       Impact factor: 3.716

8.  Effectiveness of a Psycho-Social Intervention Aimed at Reducing Attrition at Methadone Maintenance Treatment Clinics: A Propensity Score Matching Analysis.

Authors:  Xiaoyan Fan; Xiao Zhang; Huifang Xu; Fan Yang; Joseph T F Lau; Chun Hao; Jinghua Li; Yuteng Zhao; Yuantao Hao; Jing Gu
Journal:  Int J Environ Res Public Health       Date:  2019-11-07       Impact factor: 3.390

9.  Factors associated with hepatitis B vaccine series completion in a randomized trial for injection drug users reached through syringe exchange programs in three US cities.

Authors:  Sarah Bowman; Lauretta E Grau; Merrill Singer; Greg Scott; Robert Heimer
Journal:  BMC Public Health       Date:  2014-08-09       Impact factor: 3.295

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.